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Abstract 
Background: Cervical cancer is the 2nd most frequent and top killer cancer among women in Ethiopia. Prevalence 
and factors associated with visual inspection with acetic acid (VIA) positive result is not studied yet at the study area.
Methods: A cross-sectional study was conducted at Jimma model clinic of Family Guidance Association of Ethiopia, 
from September 11, 2013 to October 11, 2013. Pertinent data of 334 screened clients were transferred to Epidata ver-
sion3.1 using checklist, double data entry verification done and exported to SPSS version16.0. After cleaning the data, 
descriptive analysis was done and logistic regression model employed to identify predictors of VIA positive result. 
Statistical significance was declared at P < 0.05.
Results: Out of 334 screened clients, 43 (12.9 %) had VIA positive result. Initiation of sexual intercourse earlier than 
16 years was found to be an independent predictor increasing the risk of VIA positive by 2.2 times as compared to 
clients who started at the age of 16 or more years (AOR [95 % CI] = 2.2 [1.1, 4.3]).
Conclusions: Early initiation of sexual intercourse was an independent predictor of VIA positive result in this study. 
Thus, any cervical cancer prevention and control effort at the study area should address the problem of early initiation 
of sexual intercourse.
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Background
Cervical cancer is a disease in which the cells of the cer-
vix become abnormal and start to grow uncontrollably, 
forming tumors [1]. It is caused by the sexually transmit-
ted human papilloma virus (HPV) infection which has 
been detected in up to 99  % of women with squamous 
cervical carcinoma [2]. Young age at first intercourse 
(<16  years), multiple sexual partners, cigarette smoking 
and high parity are risk factors for HPV acquisition and 
cervical cancer.
Cancer of the cervix is the second most common can-
cer among women worldwide, with about 530,000 new 
patients diagnosed and over 270,000 deaths every year. 
It is a major cause of morbidity and mortality among 
women in low and middle income countries (LMICs) 
where more than 85  % of the global burden and deaths 
occur because of poor access to screening and treatment 
services [3, 4].
In Africa, according to most recent estimates, 80,400 
women are diagnosed with cervical cancer every year, the 
second most frequent cancer. 50,300 die from the disease 
every year, the leading cause of cancer death. Rates vary 
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substantially across regions, with the incidence and death 
rates in East Africa, the region Ethiopia belongs to, and West 
Africa five times as high as the rates in North Africa [5].
In Ethiopia, the annual number of new cervical cancer 
cases was 4648 and 3235 (69.6  %) die from the disease 
making it the 2nd most frequent and top killer cancer 
among women according to an estimate by International 
agency for research on cancer (IARC) [4]. However, the 
figures most likely under-represent actual number of 
cases and deaths, given the low level of awareness, cost, 
limited access to screening and treatment services and 
lack of a national cancer registry [6]. In order to address 
the problem, visual inspection with acetic acid (VIA) and 
cryotherapy for cervical cancer prevention among peo-
ple living with HIV/AIDS (PLWHA) had been started 
in Ethiopia on September 2010 with collaborative effort 
of Pathfinder International, Federal Ministry of Health 
(FMOH) of Ethiopia and the Stanford University Pro-
gram for International Reproductive Education and 
Services (SPIRES). However, studies on prevalence and 
factors associated with VIA positive were limited at the 
study area and this research was primarily designed to 
address that.
Methods
Family Guidance Association of Ethiopia (FGAE) is one 
of the leading non-governmental providers of sexual and 
reproductive health (SRH) care in Ethiopia. FGAE has 20 
medium SRH clinics and 27 youth centers across Ethio-
pia. This study was conducted at Jimma model clinic 
(JMC), one of the 20 medium SRH clinics of FGAE, 
Jimma town, 350  km southwest of Addis Ababa, Ethio-
pia’s capital. The catchment area of the clinic is Jimma 
town and surrounding districts. The clinic started oppor-
tunistic screening of females aged 25–45  years on Sep-
tember 2012 as per cervical cancer prevention guideline 
for low-resource settings [7]. Thus, after proper coun-
seling of clients aged 25–45 years who came for medical 
or reproductive health services, those with free will were 
screened with 5 % acetic acid and test positive cryother-
apy eligible clients were treated with cryotherapy while 
cryotherapy ineligible clients and those with lesions sus-
picious for cancer were referred to Jimma University spe-
cialized hospital (JUSH). Diagnostic criteria were as per 
cervical cancer prevention guideline for low-resource 
settings and screening results were defined as:
VIA positive: presence of raised and thickened white 
plaques or acetowhite epithelium, usually near the 
Squamo-columnar junction (SCJ).
VIA negative: presence of smooth, pink, uniform and 
featureless cervix; cervical ectropion; polyp; cervicitis; 
inflammation; and/or nabothian cyst after applying a 
dilute solution of acetic acid.
Eligible for cryotherapy: acetowhite lesion  <75  % of 
cervix; lesion does not extend onto the vaginal wall; 
and lesion extends  <2  mm beyond the diameter of the 
cryoprobe.
Ineligible for cryotherapy: acetowhite lesion  >75  % 
of cervix; lesion extends into the vaginal wall; lesion 
extends >2 mm beyond the diameter of the cryotip and 
lesion suspicious for cancer.
Suspicious for cancer: presence of cauliflower-like 
growth or ulcer; fungating and bleeding mass.
Primary data was registered on standard client evalu-
ation form for cervical cancer prevention service by 
trained general practioner and nurse. Ethical approval 
was obtained from ethical review board of Jimma Univer-
sity. A letter of support was obtained from JMC. Client 
records were treated confidentially and name of clients 
was not included in the data collection. After checking 
for integrity and plausibility, data was collected from 
standard client evaluation form for cervical cancer pre-
vention service on checklist for retrieving data from Sep-
tember 11, 2013 to October 11, 2013 and transferred to 
Epidata. Double entry verification was also made and the 
entered data was exported to SPSS version 16.0 for analy-
sis. Descriptive analysis of variables involved was done 
and Logistic regression was employed for identifying pre-
dictors of VIA positive result.
Results
Baseline characteristics of screened clients
A total of 334 clients aged 25–45  years were screened 
by (VIA) from September 2012 to October 11, 2013 at 
the study clinic. More than half (51.5  %) of them were 
in the age range 25–30  years with mean age of 32.4 
(SD5.4) years. Most of them were married (73.7 %), mul-
tiparous (69.2 %), having only one sexual partner (73.1 %) 
and had no history of STI (84.7  %). More than half of 
them were HIV negative (51.2  %) and initiated sexual 
intercourse at 16 years or older (52.4 %) with mean age at 
initiation 16.7 (SD3) years. None of the screened clients 
had ever smoked, used steroid chronically or had abnor-
mal Pap smear previously. Squamo-columnar junction 
(SCJ) was visible in all the screened clients (Table 1).
Prevalence of VIA positive result
Of 334 screened clients, 43 (12.9 %) were found to have 
VIA positive result while 287 (85.9  %) had negative 
test result. The remaining four (1.2  %) were found to 
have lesions suspicious for cancer. Fourty-two of the 43 
(97.7 %) clients with positive VIA test result were eligible 
for cryotherapy while one of the clients with positive VIA 
test result had lesion larger than cryoprobe by greater 
than 2  mm and thus not eligible. Thus, 42 clients with 
positive VIA test result who were eligible for cryotherapy 
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were treated at the clinic while one of the clients who is 
ineligible for cryotherapy is referred to JUSH along with 
the four patients who had lesions suspicious for cancer 
(Table 2).
Factors associated with VIA positive result
Age at onset of intercourse and HIV-status were 
unknown in 11 and 28 screened clients respectively 
while both age at onset of intercourse and HIV-status 
was unknown in 3 resulting in exclusion of 36 screened 
clients from logistic regression analysis. Thus, of the 334 
clients screened at the clinic, only 298 were eligible for 
logistic regression analysis (Fig. 1). Significant association 
was observed on bivariate logistic regression between 
VIA positive and age of clients and age at first inter-
course. On multivariable logistic regression, clients who 
started intercourse at less than 16  years were 2.2 times 
(AOR [95  % CI] 2.2 [1.1, 4.3]) more likely to have VIA 
positive as compared to those who started intercourse at 
the age of 16 or more years (Table 3). However, history of 
STI, number of sexual partners, HIV-status and HAART-
status were not found to be predictive of VIA positive in 
this study. 
Discussion
Of 334 screened clients, 12.9  % had VIA positive and 
those who started sexual intercourse earlier than 16 years 
were 2.2 times at higher risk as compared to those who 
started sex at the age of 16 or more. The mean age at ini-
tiation of intercourse was 16.7 (SD  =  3)  years and this 
is comparable with median age at first intercourse for 
women aged 25–49 years both in Oromia (17 years) and 
Ethiopia (16.6 years) [8].
The prevalence of VIA positive at the study clinic 
(12.9 %) was similar to study finding from central Ethio-
pia among PLWHA’s (11 %) [9] but lower than study find-
ing from southern Ethiopia among PLWHA’s (22.1  %) 
[10]. It was also similar to study finding from Madagascar 
(11.3 %) [11], Malawi (12.4 %) [11], Latin America (12 %) 
[12] and Thailand (13.3  %) [13] though it is lower than 
study findings from Nigeria (16 %) [14], Sudan (16 %) [15] 
and Bangladesh (18  %) [16]. However, it is higher than 
study findings from Uganda (7.8  %) [11] and Tanzania 
(9.7  %) [11]. The difference in prevalence could be due 
to the differences in the age of study populations [10], as 
evidenced by the two Ethiopian studies among PLWHA 
Table 1 Baseline characteristics of  clients screened using 
VIA at Family Guidance Association of Ethiopia, south west 
area office, Jimma model clinic, Jimma, 2013
Characteristics Number (%)
Age in years
 25–30 172 (51.5)
 31–35 79 (23.7)
 36–40 61 (18.3)
 41–45 22 (6.6)
Educational status
 Illiterate 73 (21.9)
 Primary 105 (31.4)
 Secondary 105 (31.4)
 Tertiary 51 (15.3)
Marital status
 Single 11 (21.9)
 Married 246 (73.7)
 Divorced 38 (11.4)
 Widowed 23 (6.9)
 Separated 16 (4.8)
Parity
 Nulliparous 31 (9.3)
 Primiparous 72 (21.6)
 Multiparous 231 (69.2)
Age at first intercourse
 <16 148 (44.3)
 16 175 (52.4)
 Unknown 11 (3.3)
Current contraceptive
 OCP 20 (6)
 DEPO 57 (17.1)
 Implanon 9 (2.7)
 Jadelle 6 (1.8)
 IUCD 6 (1.8)
 Condom 7 (2.1)
 BTL 2 (0.6)
 Dual contraception 8 (1.5)
 None 222 (66.5)
STI history
 Yes 51 (15.3)
 No 283 (84.7)
HIV sero-status
 Unknown 28 (8.4)
 Negative 171 (51.2)
 Positive 135 (40.4)
HIV positives
 On HAART 110 (81.5)
 Not on HAART 25 (18.5)
No of sexual partners
 One 244 (73.1)
 Multiple 90 (26.9)
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in which one used the age group 30–45  years [9] while 
the other used 18 years and older [10]. It may also be due 
to differences in test providers skills [17, 18] and under-
lying prevalence of other sexually transmitted infections 
[18]. The higher prevalence in Sudan [15], Nigeria [14] 
and Bangladesh [16] is most probably due to a lower 
sample size in the study, 100, 125 and 44 respectively, 
although provision of the service by laywomen, poor 
test providers skills, has also contributed to the finding 
of Bangladesh study. Further, VIA also inherently suffers 
from the same challenges as other visual interpretation 
methods including colposcopy and cytology as evidenced 
by Indian study where VIA positivity rate varied from 4 % 
to 31 % among the six gynecologists who performed the 
test [17].
Early initiation of intercourse increased the risk of VIA 
positive by 2.2 times which is similar to study from Bra-
zil (OR [95 % CI] 1.97 [1.18–3.3]) [19], Nigeria (OR [95 % 
CI] 3.7 [1.07–12.8]) [14] and India (OR [95  % CI] 3.5 
[1.1–10.9]) [20]. Early onset of sexual activity is thought 
to be associated with high risk because, during puberty, 
cervical tissue undergoes physiologic changes, transfor-
mation zone on the ectocervix is enlarged, and exposure 
to HPV at such times may facilitate infection which may 
make this area more vulnerable to development of dys-
plasia, a cervical squamous precancer [21]. Kenyan study 
has also showed higher risk of VIA positive among HIV 
patients (AOR [95  % CI]  4.8 [1.8–12.4]), those having 
multiple sexual partners (AOR [95 % CI] 3.8 [1.1–13.5]) 
[22] and HIV patients not on antiretroviral therapy 
(HAART) (AOR [95  % CI]  2.21 [1.28–3.83]) [23]. Tan-
zanian study showed higher risk of VIA positive among 
widowed/separated (OR [95 % CI]  1.41 [1.17–1.66]) and 
grand multipara women (OR [95 % CI] 3.19 [1.84–5.48]) 
[24]. South Ethiopian study reported higher risk among 
those with history of sexually transmitted disease (AOR 
[95 % CI] 2.30 [1.23, 4.29]) [10]. However, age of the cli-
ent, history of STI, number of sexual partners, HIV-sta-
tus and HAART-status were not found to be predictive of 
VIA positive in this study.
The role of HIV in precancerous cervical lesion is 
thought to be mediated through immune suppression [1]. 
Table 2 VIA test result, cryotherapy eligibility and  rea-
sons for  referral among  clients screened at  Family Guid-
ance Association of Ethiopia, south west area office, Jimma 
model clinic, Jimma, 2013
Characteristics Number (%)
VIA test result
 Positive 43 (12.9)
 Negative 287 (85.9)
 Suspicious for cancer 4 (1.2)
Cryotherapy eligibility
 Eligible 42 (97.7)
 Ineligible 1 (2.3)
Reasons for referral
 Suspicious for cancer 4 (80)
 Lesion larger than cryoprobe >2 mm 1 (20)
Fig. 1 Profile of clients screened using VIA at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, 2013. 
Three hundred and thirty-four clients were screened using VIA at Jimma model clinic. Age at onset of intercourse and HIV-status were unknown in 
11 and 28 screened clients respectively while both age at onset of intercourse and HIV-status were unknown in 3 resulting in exclusion of a total of 
36 screened clients from logistic regression analysis. Thus, only 298 were eligible for logistic regression analysis
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Thus, prompt initiation of HAART through an early enroll-
ment into care has an impact on reducing the prevalence 
and progression of cervical precancerous lesions [23]. 
Women who are separated or widowed may have higher 
number of lifetime sexual partners in comparison with 
married women and as number of lifetime sexual partners 
increases, the risk of HPV infection increases and thus they 
are more susceptible for developing precancerous lesions 
[25]. High parity increases the risk of precancerous cervi-
cal lesions most likely due to repeated cervical trauma dur-
ing consecutive births and hormonal adjustment during 
and after pregnancies which may create an entry point for 
the HPV virus [26]. History of sexually transmitted disease 
increases the risk of precancerous cervical lesions due to 
the sexually transmitted nature of HPV infection [27].
Conclusions
In this study, 12.9  % of screened clients had VIA posi-
tive and early initiation of intercourse was found to be an 
independent predictor increasing the risk by 2.2 times. 
Thus, there is a need to introduce HPV vaccination for 
girls aged 9–13 years, advocate for the norm of virginity till 
marriage, avoid early age at marriage, promote delaying of 
age at initiation of sexual intercourse, give sexuality educa-
tion tailored to age and culture and promote and provide 
condom for those engaged in sexual activity in addressing 
early initiation of sexual intercourse (Additional files 1, 2).
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